Literature DB >> 17975665

When it comes to opiates, just say NO.

Gavril W Pasternak1.   

Abstract

Repeated use of opiate analgesic drugs such as morphine for the relief of chronic pain may result in the development of opiate tolerance and dependence, leading to a narrowing of the drug's therapeutic index and increased side effects. Previous preclinical work has shown that interruption of a signaling cascade involving the N-methyl-D-aspartate receptor and NO prevents morphine tolerance. In this issue of the JCI, Muscoli and colleagues extend our understanding of the role of NO in tolerance by demonstrating that, in mice, tolerance to chronic morphine administration is associated with NO conversion to peroxynitrite, which accumulates and nitrates tyrosine moieties within various proteins in the spinal cord (see the related article beginning on page 3530). This and other data suggest that peroxynitrite plays a role in opiate tolerance and that regulation of peroxynitrite may be utilized for the management of opiate-induced tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975665      PMCID: PMC2045628          DOI: 10.1172/JCI34035

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

Review 1.  Clinical pharmacology of opioids for pain.

Authors:  Charles E Inturrisi
Journal:  Clin J Pain       Date:  2002 Jul-Aug       Impact factor: 3.442

2.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

Authors:  K A Trujillo; H Akil
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

3.  Cellular site of opiate dependence.

Authors:  H O Collier
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

4.  Current pharmacotherapy of chronic pain.

Authors:  R K Portenoy
Journal:  J Pain Symptom Manage       Date:  2000-01       Impact factor: 3.612

5.  Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs.

Authors:  M King; W Su; A Chang; A Zuckerman; G W Pasternak
Journal:  Nat Neurosci       Date:  2001-03       Impact factor: 24.884

6.  Increased brain P-glycoprotein in morphine tolerant rats.

Authors:  C L Aquilante; S P Letrent; G M Pollack; K L Brouwer
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

7.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide.

Authors:  S R Jaffrey; H Erdjument-Bromage; C D Ferris; P Tempst; S H Snyder
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

8.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Michael M Ndengele; Vincenzo Mollace; Frank Porreca; Francesca Fabrizi; Emanuela Esposito; Emanuela Masini; George M Matuschak; Daniela Salvemini
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat.

Authors:  S Ben-Eliyahu; P Marek; A L Vaccarino; J S Mogil; W F Sternberg; J C Liebeskind
Journal:  Brain Res       Date:  1992-03-20       Impact factor: 3.252

10.  Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites.

Authors:  S C Roerig; S M O'Brien; J M Fujimoto; G L Wilcox
Journal:  Brain Res       Date:  1984-08-13       Impact factor: 3.252

View more
  16 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

2.  Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs.

Authors:  Jin Xu; Andrew J Faskowitz; Grace C Rossi; Mingming Xu; Zhigang Lu; Ying-Xian Pan; Gavril W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

3.  Removal of polysialylated neural cell adhesion molecule increases morphine analgesia and interferes with tolerance in mice.

Authors:  Abderrahman El Maarouf; Yuri Kolesnikov; Gavril Pasternak; Urs Rutishauser
Journal:  Brain Res       Date:  2011-06-14       Impact factor: 3.252

Review 4.  Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  Jennifer L Whistler
Journal:  Drug Alcohol Depend       Date:  2012-01-09       Impact factor: 4.492

5.  Spinal matrix metalloproteinase-9 contributes to physical dependence on morphine in mice.

Authors:  Wen-Tao Liu; Yuan Han; Yue-Peng Liu; Angela A Song; Beth Barnes; Xue-Jun Song
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

6.  Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor.

Authors:  Li He; Joseph A Kim; Jennifer L Whistler
Journal:  FASEB J       Date:  2009-08-13       Impact factor: 5.191

7.  Understanding Opioid Actions, Pain and Analgesia: A Tribute to Dr. Gavril Pasternak.

Authors:  Kelly M Standifer; Charles E Inturrisi; Kathleen M Foley; Ying-Xian Pan
Journal:  Cell Mol Neurobiol       Date:  2021-05-12       Impact factor: 5.046

Review 8.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

9.  Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice.

Authors:  Yuan Han; Xue-Song Song; Wen-Tao Liu; Mark Henkemeyer; Xue-Jun Song
Journal:  Mol Pain       Date:  2008-11-21       Impact factor: 3.395

10.  Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils.

Authors:  Elise Glattard; Ingeborg D Welters; Thomas Lavaux; Arnaud H Muller; Alexis Laux; Dan Zhang; Alexander R Schmidt; François Delalande; Benoît-Joseph Laventie; Sylvie Dirrig-Grosch; Didier A Colin; Alain Van Dorsselaer; Dominique Aunis; Marie-Hélène Metz-Boutigue; Francis Schneider; Yannick Goumon
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.